Medicare Enrolled

Dr. Matthew Witmer, MD

Ophthalmology · Rochester, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
160 SAWGRASS DR, Rochester, NY 14620
5854423411
In practice since 2007 (18 years)
NPI: 1235321167 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Witmer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Witmer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Witmer

Dr. Matthew Witmer is an ophthalmology specialist in Rochester, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Witmer performed 8,142 Medicare services across 1,097 unique beneficiaries.

Between the years covered by Open Payments, Dr. Witmer received a total of $57,313 from 15 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Witmer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 9% volume in NY $57,313 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,142
Medicare services
Top 9% in NY for ophthalmology
1,097
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~452 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
5,220 $29 $43
Aflibercept eye injection (Eylea) 896 $678 $1,058
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
790 $30 $134
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
608 $92 $263
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
346 $93 $206
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
123 $53 $153
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
94 $62 $310
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $118 $575
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
12 $29 $107
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$57,313
Total received (2018-2024)
Avg $8,188/year across 7 years
Top 4% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52,803 (92.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,833 (4.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,677 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,516
2023
$16,241
2022
$1,138
2021
$3,995
2020
$6,977
2019
$2,945
2018
$11,501

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$11,475
ABBVIE INC.
$2,833
Alimera Sciences, Inc.
$90
Genentech USA, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$37
Sandoz Inc.
$22
Top 3 companies account for 99.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$27,278
Allergan Inc.
$13,998
Allergan, Inc.
$10,840
ABBVIE INC.
$3,520
Regeneron Healthcare Solutions, Inc.
$497
Genentech USA, Inc.
$320
Alimera Sciences, Inc.
$254
Bausch & Lomb, a division of Bausch Health US, LLC
$158
Alcon Vision LLC
$140
Coherus Biosciences Inc.
$84
EyePoint Pharmaceuticals US, Inc.
$84
Novartis Pharmaceuticals Corporation
$70
AbbVie Inc.
$31
Sandoz Inc.
$22
Vanda Pharmaceuticals Inc.
$17
Top 3 companies account for 90.9% of all-time payments
Associated products mentioned in payments ›
BEOVU · Centurion · Cimerli · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Hetlioz · ILUVIEN · Iluvien · Izervay · Lucentis · OZURDEX · RETISERT · STELLARIS PC · SUSVIMO · VABYSMO · VISUDYNE · Vabysmo · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for ophthalmology in NY.

Looking for an ophthalmology specialist in Rochester?
Compare ophthalmologists in the Rochester area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
67
Per 100K population
8.9
County median income
$74,409
Nearest hospital
ROCHESTER PSYCHIATRIC CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Witmer is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Witmer experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Witmer performed 5,220 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Witmer receive payments from pharmaceutical companies?
Yes. Dr. Witmer received a total of $57,313 from 15 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Witmer's costs compare to other ophthalmologists in Rochester?
Dr. Witmer's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Witmer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →